NUVL Competitors & Alternatives
Compare Nuvalent Inc with similar stocks in the same industry
Biotechnology
NUVL
Main Stock$123.73
Tradestie Score
61
Market Cap
$5.95B
Analyst Upside
+1.1%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$35.13
|
$10.76B | - | 59 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$79.76
|
$10.74B | - | 58 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$58.99
|
$10.53B | 41.6 | 63 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$81.80
|
$10.49B | - | 64 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$77.19
|
$10.22B | - | 62 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$528.10
|
$10.01B | - | 59 | Compare |
|
TECH
Bio-Techne Corp.
|
$70.83
|
$9.33B | 101.4 | 53 | Compare |
|
CORT
Corcept Therapeutics Inc.
|
$90.21
|
$8.88B | 248.4 | 58 | Compare |
|
HALO
Halozyme Therapeutics, Inc.
|
$79.45
|
$8.77B | 27.0 | 61 | Compare |
|
RVMD
Revolution Medicines, Inc. Common Stock
|
$189.24
|
$8.57B | - | 62 | Compare |
More NUVL Analysis
Data updated: Jul 04, 2026 | Industry: Biotechnology (SIC 2834)
231 stocks in this industry